178 related articles for article (PubMed ID: 11978573)
1. Cutaneous necrosis revealing the coexistence of an antiphospholipid syndrome with acquired protein S deficiency, factor V Leiden and hyperhomocysteinemia.
Combemale P; Amiral J; Estival JL; Dupin M; Chouvet B; Berruyer M
Eur J Dermatol; 2002; 12(3):278-82. PubMed ID: 11978573
[TBL] [Abstract][Full Text] [Related]
2. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA
Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
4. Thrombophilias and recurrent pregnancy loss.
Kutteh WH; Triplett DA
Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
[TBL] [Abstract][Full Text] [Related]
5. [Association of tow thrombotic risk factors: factor V Leiden and hyperhomocysteinemia. A case report].
Znazen R; Guermazi S; Karoui M
Pathol Biol (Paris); 2007; 55(3-4):163-6. PubMed ID: 16707235
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
7. [Association of celiac disease and cerebral venous thrombosis: report of two cases].
Boucelma M; Saadi M; Boukrara H; Bensalah D; Hakem D; Berrah A
J Mal Vasc; 2013 Feb; 38(1):47-51. PubMed ID: 23287617
[TBL] [Abstract][Full Text] [Related]
8. [Myocardial infarction as an initial symptom of antiphospholipid syndrome, factor V Leiden mutation, and hyperhomocysteinemia].
Dropiński J; Wegrzyn W; Szczeklik W; Krzanowski M
Pol Arch Med Wewn; 2004 Jan; 111(1):63-7. PubMed ID: 15088423
[TBL] [Abstract][Full Text] [Related]
9. Association of primary antiphospholipid syndrome with inherited activated protein C resistance.
Picillo U; De Lucia D; Palatiello E; Scuotto A; Marcialis MR; Pezzella S; Tirri G
J Rheumatol; 1998 Jun; 25(6):1232-4. PubMed ID: 9632093
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of hemostasis in venous thromboembolism pathology].
Gaussem P; Siguret V; Aiach M
Ann Biol Clin (Paris); 1998; 56(1):49-56. PubMed ID: 9754222
[TBL] [Abstract][Full Text] [Related]
11. [Necrotic leg ulcers induced by vitamin K antagonists: five cases].
Bezier M; Perceau G; Reguiai Z; Remy-Leroux V; Tchen T; Durlach A; Grange F; Nguyen P; Bernard P
Ann Dermatol Venereol; 2011 Oct; 138(10):657-63. PubMed ID: 21978501
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
13. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
[TBL] [Abstract][Full Text] [Related]
14. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
Deschiens MA; Conard J; Horellou MH; Ameri A; Preter M; Chedru F; Samama MM; Bousser MG
Stroke; 1996 Oct; 27(10):1724-30. PubMed ID: 8841318
[TBL] [Abstract][Full Text] [Related]
15. Influence of inherited and acquired thrombophilic defects on the clinical manifestations of mixed cryoglobulinaemia.
Casato M; Carlesimo M; Francia A; Timarco C; Antenucci A; Bove M; Martini H; Visentini M; Fiorilli M; Conti L
Rheumatology (Oxford); 2008 Nov; 47(11):1659-63. PubMed ID: 18713771
[TBL] [Abstract][Full Text] [Related]
16. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
[TBL] [Abstract][Full Text] [Related]
17. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
[TBL] [Abstract][Full Text] [Related]
18. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of thrombotic children with malignancy.
Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
